Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. González San Segundo is active.

Publication


Featured researches published by C. González San Segundo.


Revista Clinica Espanola | 2000

Metástasis mamarias de rabdomiosarcoma embrionario: a propósito de dos casos y revisión de la literatura

Ja Santos Miranda; C. González San Segundo; L. Carretero Albiñana

La presencia de metastasis mamarias es un hecho poco frecuente en Oncologia. En los ninos y adultos jovenes el tumor primario mas frecuente es el rabdomiosarcoma, siendo los rabdomiosarcomas primarios de mama excepcionales. Se describen dos casos de rabdomiosarcoma metastasico en mama en dos adolescentes con varias caracteristicas atipicas en su presentacion: la variedad embrionaria y la localizacion primaria en seno maxilar. Se analizan los casos descritos en la literatura hasta la actualidad, estudiando los datos epidemiologicos, clinicos, diagnosticos y terapeuticos de esta rara entidad.


Clinical & Translational Oncology | 2018

Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG

I. Henriquez; A. Rodríguez-Antolín; Javier Cassinello; C. González San Segundo; M. Unda; Enrique Gallardo; José López-Torrecilla; A. Juárez; José María Arranz

PurposeProstate cancer (PCa) is the most prevalent malignancy in men and the second cause of mortality in industrialized countries.MethodsBased on Spanish Register of PCa, the incidence of high-risk PCa is 29%, approximately. In spite of the evidence-based beneficial effect of radiotherapy and androgen deprivation therapy in high-risk PCa, these patients (pts) are still a therapeutic challenge for all specialists involved, in part due to the absence of comparative studies to establish which of the present disposable treatments offer better results.ResultsNowadays, high-risk PCa definition is not well consensual through the published oncology guides. Clinical stage, tumour grade, and number of risk factors are relevant to be considered on PCa prognosis. However, these factors are susceptible to change depending on when surgical or radiation therapy is considered to be the treatment of choice. Other factors, such as reference pathologist, different diagnosis biopsy schedules, surgical or radiotherapy techniques, adjuvant treatments, biochemical failures, and follow-up, make it difficult to compare the results between different therapeutic options.ConclusionsThis article reviews important issues concerning high-risk PCa. URONCOR, GUO, and SOGUG on behalf of the Spanish Groups of Uro-Oncology Societies have reached a consensus addressing a practical recommendation on definition, diagnosis, and management of high-risk PCa.


Anales De Medicina Interna | 2007

Radioterapia esplénica: a próposito de 8 casos. Indicaciones y revisión de la literatura

C. Ibáñez Villoslada; C. González San Segundo; M. V. de Torres Olombrada; R. García García; Ja Santos Miranda

Clinical indications of splenic irradiation in haematological disorders include the irradiation in lymphoproliferative disorders with spleen infiltration, palliative treatment of splenomegaly in malignant diseases like chronic lymphocytic leukaemia or myeloproliferative disorders, with the purpose of relief from abdominal pain associated with capsular enlargement size and decrease cytopenias secundaries to hypersplenism. This paper reports our experience with spleen irradiation in the Hospital General Universitario Gregorio Maranon in the last five years, and analizes indications, results and toxicity, and an actual review of the literature.


International Journal of Radiation Oncology Biology Physics | 2014

Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer

A. Zapatero; A. Guerrero; José-Luis Maldonado; Amelia Álvarez; C. González San Segundo; M.D.L.A. Cabeza Rodriguez; Víctor Macías; A. Pedro-Olive; Francesc Casas; Ana Boladeras; C. Martin de Vidales; M. Vázquez de La Torre; Felipe A. Calvo


Clinical & Translational Oncology | 2015

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

A. Zapatero; C. González San Segundo; Ana Boladeras; A. Gómez Caamaño; J. López Torrecilla; X. Maldonado


International Journal of Radiation Oncology Biology Physics | 2016

Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial

A. Zapatero; A. Guerrero; José-Luis Maldonado; Anton Alvarez; C. González San Segundo; M.D.L.A. Cabeza Rodriguez; Víctor Macías; Ana Pedro; Francesc Casas; Ana Boladeras; C. Martin de Vidales; M. Vázquez de La Torre; Felipe A. Calvo


European Urology Supplements | 2017

Questionnaire to evaluate Prostate Cancer Multidisciplinary committees in Spain

Javier Cassinello; I. Henríquez López; A. González Del Alba; C. González San Segundo; J. López Torrecilla; Enrique Gallardo; A. Rodríguez Antolín; A. Juárez; M. Unda; José María Arranz


Radiotherapy and Oncology | 2014

PO-0728: Influence of whole pelvis radiotherapy in high risk PC outcomes treated with radical intention. RECAP data base

J. López Torrecilla; J. Muñoz García; J. Jové Teixidó; A. Hervás Morón; M. Casaña Giner; J.L. Mengual Cloquell; Y. Ríos Kavadoy; C. González San Segundo; M. Porras Martínez; A. Gómez Caamaño


Reports of Practical Oncology & Radiotherapy | 2013

Best oral presentation: Long-term toxicity following high-dose radiotherapy and androgen deprivation for prostate cancer: Report of phase-III clinical trial DART 01/05

Amelia Álvarez; A. Zapatero; A. Guerrero; X. Maldonado; C. González San Segundo; A. Cabeza; Víctor Macías; Francesc Casas; A. Pedro-Olive; Ana Boladeras; C. Martin de Vidales; M. Vázquez de La Torre; Felipe A. Calvo


Reports of Practical Oncology & Radiotherapy | 2013

Best oral presentation: Multi-institutional outcomes following external beam radiation therapy and androgen deprivation therapy in patients with extreme-risk prostate cancer

A. Gómez-Iturriaga; M. Cabeza; J. Pastor; J. Jove; M. Casaña; J. Mengual; Javier Muñoz; Asunción Hervás; I. Henriquez; C. Carvajal; C. González San Segundo; A. Gómez Caamaño; A. Zapatero; V. Muñoz; J. Clemente; F. Lopez Soler; E. Villafranca; M. Vallejo

Collaboration


Dive into the C. González San Segundo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Felipe A. Calvo

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Enrique Gallardo

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

I. Henriquez

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José-Luis Maldonado

Centro de Investigaciones en Optica

View shared research outputs
Top Co-Authors

Avatar

Anton Alvarez

Mexican Institute of Petroleum

View shared research outputs
Researchain Logo
Decentralizing Knowledge